Amgen is a leading biotechnology company that specializes in the development and manufacturing of innovative medicines. With a commitment to transforming the lives of patients, Amgen focuses on discovering, developing, and delivering breakthrough therapies for serious illnesses. The company's is centered around its mission to serve patients by advancing science and bringing innovative treatments to the market. Amgen's dedication to scientific excellence is evident in its robust research and development efforts, which aim to address unmet medical needs and improve patient outcomes.
As a global biopharmaceutical company, Amgen operates in more than 100 countries and has a diverse portfolio of products that span a wide range of therapeutic areas, including oncology, cardiology, nephrology, and neuroscience. The company's commitment to innovation is underscored by its investment in cutting-edge technologies and collaborations with academic institutions and other industry partners. Amgen's corporate description emphasizes its role as a pioneer in biotechnology, leveraging its expertise in molecular biology and genetics to develop novel therapies that target the underlying causes of diseases.